Study of 3D189 in Patients With Hematologic Malignancies

NCT05320809 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Leukemia
Multiple Myeloma
Non-Hodgkin Lymphoma
Higher-risk Myelodysplastic Syndrome

Interventions

BIOLOGICAL: 3D189

Sponsor

3D Medicines